| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1081/LPR-120017482 |
| P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.1081/LPR-120017482 |
| P698 | PubMed publication ID | 12725720 |
| P2093 | author name string | Yechezkel Barenholz | |
| P2860 | cites work | Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation | Q35989488 |
| Liposomes: preparation, characterization, and preservation | Q39636135 | ||
| Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance | Q43600618 | ||
| DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice | Q43665622 | ||
| A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains. | Q50686159 | ||
| Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery | Q71561923 | ||
| Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases | Q72927459 | ||
| Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models | Q73343399 | ||
| Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice | Q73410636 | ||
| A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice | Q77296872 | ||
| A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice | Q77296875 | ||
| Development of liposomal anthracyclines: from basics to clinical applications | Q77314544 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmaceutical science | Q7180763 |
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Journal of Liposome Research | Q6295453 |
| P1476 | title | Relevancy of drug loading to liposomal formulation therapeutic efficacy | |
| Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy | |||
| P478 | volume | 13 |
| Q30448009 | A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery |
| Q46099472 | A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions |
| Q46358000 | Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. |
| Q50515897 | Cholesterol derivative-based liposomes for gemcitabine delivery: preparation, in vitro, and in vivo characterization. |
| Q42881401 | Computer-aided design of liposomal drugs: In silico prediction and experimental validation of drug candidates for liposomal remote loading |
| Q33601744 | Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates |
| Q36350400 | Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology. |
| Q87319599 | Enhancement of microbial hydroxylation of 13-ethyl-gon-4-ene-3,17-dione by Metarhizium anisopliae using nano-liposome technique |
| Q43245706 | Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation |
| Q38011267 | Extended release formulations for local anaesthetic agents |
| Q28477392 | Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids |
| Q30464743 | Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound |
| Q47577461 | Formulation and characterization of alprazolam-loaded nanoliposomes: screening of process variables and optimizing characteristics using RSM. |
| Q41201713 | Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes |
| Q30366990 | Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. |
| Q37963493 | Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer |
| Q58753369 | Liposomal Form of the Echinochrome-Carrageenan Complex |
| Q38214155 | Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa |
| Q47975293 | Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases |
| Q94336713 | Literature alerts |
| Q39434344 | Microfluidic approach for highly efficient synthesis of heparin-based bioconjugates for drug delivery |
| Q35567800 | Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation |
| Q90713983 | Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy |
| Q37056787 | Polymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide). |
| Q42322486 | Quantitative structure-property relationship modeling of remote liposome loading of drugs |
| Q45974649 | Rapid and efficient method for the size separation of homogeneous fluorescein-encapsulating liposomes. |
| Q37587698 | Remote loading of preencapsulated drugs into stealth liposomes |
| Q89241857 | The Positive Role of Curcumin-Loaded Salmon Nanoliposomes on the Culture of Primary Cortical Neurons |
| Q53687867 | The significance of drug-to-lipid ratio to the development of optimized liposomal formulation. |
Search more.